Canagliflozin vs Rituximab

## Canagliflozin vs Rituximab: Overview

This comparison examines the pharmacological differences between **Canagliflozin** and **Rituximab**.

## Mechanism of Action

**Canagliflozin**: Selective SGLT2 inhibitor reducing renal glucose reabsorption and lowering blood glucose.

**Rituximab**: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.

## Pharmacokinetics

**Half-life**: Canagliflozin — 10.6 hours; Rituximab — 22 days.

## Chemical Properties

**Molecular Formula**: Canagliflozin — C24H25FO5S; Rituximab — N/A.

**Molecular Weight**: Canagliflozin — 444.5170 g/mol; Rituximab — N/A.

**Type**: Canagliflozin — Small molecule; Rituximab — Antibody.